BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andresen V, Camilleri M. Irritable bowel syndrome: recent and novel therapeutic approaches. Drugs. 2006;66:1073-1088. [PMID: 16789793 DOI: 10.2165/00003495-200666080-00004] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Spinelli A. Irritable bowel syndrome. Clin Drug Investig. 2007;27:15-33. [PMID: 17177577 DOI: 10.2165/00044011-200727010-00002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
2 Panteleev SS, Busygina II, Lyubashina OA. Effects of Selective Blockade of 5-HT3 Receptors on Physiological Markers of Abdominal Pain in Conscious Dogs. Neurosci Behav Physi 2015;45:263-70. [DOI: 10.1007/s11055-015-0066-z] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Yaoita F, Muto M, Murakami H, Endo S, Kozawa M, Tsuchiya M, Tadano T, Tan-no K. Involvement of peripheral alpha2A adrenoceptor in the acceleration of gastrointestinal transit and abdominal visceral pain induced by intermittent deprivation of REM sleep. Physiology & Behavior 2018;186:52-61. [DOI: 10.1016/j.physbeh.2018.01.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Camilleri M. Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation. Neurogastroenterol Motil. 2008;20:971-979. [PMID: 18715494 DOI: 10.1111/j.1365-2982.2008.01183.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
5 Lackner JM, Jaccard J, Krasner SS, Katz LA, Gudleski GD, Blanchard EB. How does cognitive behavior therapy for irritable bowel syndrome work? A mediational analysis of a randomized clinical trial. Gastroenterology. 2007;133:433-444. [PMID: 17681164 DOI: 10.1053/j.gastro.2007.05.014] [Cited by in Crossref: 102] [Cited by in F6Publishing: 85] [Article Influence: 6.8] [Reference Citation Analysis]
6 Paine P. Review article: current and future treatment approaches for pain in IBS. Aliment Pharmacol Ther 2021;54 Suppl 1:S75-88. [PMID: 34927753 DOI: 10.1111/apt.16550] [Reference Citation Analysis]
7 Nam Y, Min YS, Sohn UD. Recent advances in pharmacological research on the management of irritable bowel syndrome. Arch Pharm Res 2018;41:955-66. [PMID: 30132170 DOI: 10.1007/s12272-018-1068-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
8 Basaranoglu M, Celebi S, Ataseven H, Rahman S, Deveci SE, Acık Y. Prevalence and Consultation Behavior of Self-Reported Rectal Bleeding by Face-to-Face Interview in an Asian Community. Digestion 2008;77:10-5. [DOI: 10.1159/000114827] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
9 Zádori ZS, Shujaa N, Brancati SB, Hein L, Gyires K. Both α2B- and α2C-adrenoceptor subtypes are involved in the mediation of centrally induced gastroprotection in mice. Eur J Pharmacol 2011;669:115-20. [PMID: 21816147 DOI: 10.1016/j.ejphar.2011.07.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
10 Pregun I, Herszényi L, Juhász M, Miheller P, Tulassay Z. Novel therapeutic approaches in the treatment of irritable bowel syndrome. Orvosi Hetilap 2007;148:923-8. [DOI: 10.1556/oh.2007.27995] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
11 Zhang XJ, Li Z, Leung WM, Liu L, Xu HX, Bian ZX. The analgesic effect of paeoniflorin on neonatal maternal separation-induced visceral hyperalgesia in rats. J Pain. 2008;9:497-505. [PMID: 18387856 DOI: 10.1016/j.jpain.2007.12.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
12 Hamaguchi T, Fukudo S, Kanazawa M, Tomiie T, Shimizu K, Oyama M, Sakurai K. Changes in salivary physiological stress markers induced by muscle stretching in patients with irritable bowel syndrome. Biopsychosoc Med. 2008;2:20. [PMID: 18983682 DOI: 10.1186/1751-0759-2-20] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
13 Sweetser S, Camilleri M, Linker Nord SJ, Burton DD, Castenada L, Croop R, Tong G, Dockens R, Zinsmeister AR. Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome? Am J Physiol Gastrointest Liver Physiol. 2009;296:G1299-G1306. [PMID: 19342506 DOI: 10.1152/ajpgi.00011.2009] [Cited by in Crossref: 81] [Cited by in F6Publishing: 85] [Article Influence: 6.2] [Reference Citation Analysis]
14 Watier A, Rigaud J, Labat JJ. [Irritable bowel syndrome, levator ani syndrome, proctalgia fugax and chronic pelvic and perineal pain]. Prog Urol 2010;20:995-1002. [PMID: 21056377 DOI: 10.1016/j.purol.2010.08.060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
15 Mangel AW, Fehnel SE. Design of treatment trials in irritable bowel syndrome: opioid agonists and atypical benzodiazepine antagonists. Neurogastroenterol Motil 2008;20:1086-93. [PMID: 18826559 DOI: 10.1111/j.1365-2982.2008.01198.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
16 Zhu WL, Li Y, Wei HF, Ren XX, Sun J, Zhang LF, Zhu J. Effect of electro-acupuncture at different acupoints on neuropeptide and somatostatin in rat brain with irritable bowel syndrome. Chin J Integr Med. 2012;18:288-292. [PMID: 22457140 DOI: 10.1007/s11655-011-0795-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
17 Uranga JA, Vera G, Abalo R. Cannabinoid pharmacology and therapy in gut disorders. Biochem Pharmacol 2018;157:134-47. [PMID: 30076849 DOI: 10.1016/j.bcp.2018.07.048] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
18 Góngora-Benítez M, Tulla-Puche J, Albericio F. Constella™(EU)-Linzess™(USA): the last milestone in the long journey of the peptide linaclotide and its implications for the future of peptide drugs. Future Med Chem 2013;5:291-300. [PMID: 23464519 DOI: 10.4155/fmc.13.5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
19 Grudell AB, Camilleri M, Jensen KL, Foxx-Orenstein AE, Burton DD, Ryks MD, Baxter KL, Cox DS, Dukes GE, Kelleher DL. Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health. Am J Physiol Gastrointest Liver Physiol. 2008;294:G1114-G1119. [PMID: 18372395 DOI: 10.1152/ajpgi.00051.2008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
20 Jones M, Koloski N, Boyce P, Talley NJ. Pathways connecting cognitive behavioral therapy and change in bowel symptoms of IBS. J Psychosom Res. 2011;70:278-285. [PMID: 21334499 DOI: 10.1016/j.jpsychores.2010.10.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
21 Kim JJ, Khan WI. 5-HT7 receptor signaling: improved therapeutic strategy in gut disorders. Front Behav Neurosci. 2014;8:396. [PMID: 25565996 DOI: 10.3389/fnbeh.2014.00396] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
22 Fichna J, Sibaev A, Sałaga M, Sobczak M, Storr M. The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice. Neurogastroenterol Motil 2013;25:e550-9. [PMID: 23692073 DOI: 10.1111/nmo.12158] [Cited by in F6Publishing: 24] [Reference Citation Analysis]
23 Gach K, do-Rego JC, Fichna J, Storr M, Delbro D, Toth G, Janecka A. Synthesis and biological evaluation of novel peripherally active morphiceptin analogs. Peptides. 2010;31:1617-1624. [PMID: 20434497 DOI: 10.1016/j.peptides.2010.04.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
24 Antonioli L, Fornai M, Colucci R, Ghisu N, Tuccori M, Del Tacca M, Blandizzi C. Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications. Pharmacol Ther 2008;120:233-53. [PMID: 18848843 DOI: 10.1016/j.pharmthera.2008.08.010] [Cited by in Crossref: 87] [Cited by in F6Publishing: 83] [Article Influence: 6.2] [Reference Citation Analysis]
25 Kojima S, Tohei A, Ikeda M, Anzai N. An Endogenous Tachykinergic NK2/NK3 Receptor Cascade System Controlling the Release of Serotonin from Colonic Mucosa. Curr Neuropharmacol 2015;13:830-5. [PMID: 26630961 DOI: 10.2174/1570159x13666150825220524] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Niesler B, Walstab J, Combrink S, Möller D, Kapeller J, Rietdorf J, Bönisch H, Göthert M, Rappold G, Brüss M. Characterization of the novel human serotonin receptor subunits 5-HT3C,5-HT3D, and 5-HT3E. Mol Pharmacol. 2007;72:8-17. [PMID: 17392525 DOI: 10.1124/mol.106.032144] [Cited by in Crossref: 114] [Cited by in F6Publishing: 102] [Article Influence: 7.6] [Reference Citation Analysis]
27 Carter NJ, Scott LJ. Lubiprostone: In Constipation-Predominant Irritable Bowel Syndrome. Drugs 2009;69:1229-37. [DOI: 10.2165/00003495-200969090-00007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
28 Shrivastava A, Mittal A. A Mini Review on Characteristics and Analytical Methods of Otilonium Bromide. Crit Rev Anal Chem 2021;:1-9. [PMID: 34039224 DOI: 10.1080/10408347.2021.1913983] [Reference Citation Analysis]
29 Hobson AR, Aziz Q. Modulation of visceral nociceptive pathways. Current Opinion in Pharmacology 2007;7:593-7. [DOI: 10.1016/j.coph.2007.09.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
30 Andresen V, Camilleri M, Busciglio IA, Grudell A, Burton D, McKinzie S, Foxx-Orenstein A, Kurtz CB, Sharma V, Johnston JM. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Gastroenterology. 2007;133:761-768. [PMID: 17854590 DOI: 10.1053/j.gastro.2007.06.067] [Cited by in Crossref: 179] [Cited by in F6Publishing: 158] [Article Influence: 11.9] [Reference Citation Analysis]
31 Cervia D, Bagnoli P. An update on somatostatin receptor signaling in native systems and new insights on their pathophysiology. Pharmacol Ther 2007;116:322-41. [PMID: 17719647 DOI: 10.1016/j.pharmthera.2007.06.010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 3.5] [Reference Citation Analysis]
32 Saps M, Hudgens S, Mody R, Lasch K, Harikrishnan V, Baum C. Seasonal Patterns of Abdominal Pain Consultations Among Adults and Children. Journal of Pediatric Gastroenterology & Nutrition 2013;56:290-6. [DOI: 10.1097/mpg.0b013e3182769796] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
33 Sikander A, Rana SV, Sharma SK, Sinha SK, Arora SK, Prasad KK, Singh K. Association of alpha 2A adrenergic receptor gene (ADRAlpha2A) polymorphism with irritable bowel syndrome, microscopic and ulcerative colitis. Clin Chim Acta. 2010;411:59-63. [PMID: 19833115 DOI: 10.1016/j.cca.2009.10.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
34 Adamska A, Kluczyk A, Cerlesi MC, Calo G, Janecka A, Borics A. Synthesis, biological evaluation and structural analysis of novel peripherally active morphiceptin analogs. Bioorganic & Medicinal Chemistry 2016;24:1582-8. [DOI: 10.1016/j.bmc.2016.02.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Pasricha PJ. Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders. Gastroenterology. 2007;132:2287-2290. [PMID: 17570201 DOI: 10.1053/j.gastro.2007.04.057] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 4.8] [Reference Citation Analysis]
36 Ma XP, Tan LY, Yang Y, Wu HG, Jiang B, Liu HR, Yang L. Effect of electro-acupuncture on substance P, its receptor and corticotropin-releasing hormone in rats with irritable bowel syndrome. World J Gastroenterol 2009; 15(41): 5211-5217 [PMID: 19891022 DOI: 10.3748/wjg.15.5211] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
37 Zádori ZS, Fehér Á, Al-khrasani M, Lackó E, Tóth VE, Brancati SB, Hein L, Mátyus P, Gyires K. Imidazoline versus alpha2-adrenoceptors in the control of gastric motility in mice. European Journal of Pharmacology 2013;705:61-7. [DOI: 10.1016/j.ejphar.2013.02.043] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
38 León-Ponte M, Ahern GP, O'Connell PJ. Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood 2007;109:3139-46. [PMID: 17158224 DOI: 10.1182/blood-2006-10-052787] [Cited by in Crossref: 180] [Cited by in F6Publishing: 172] [Article Influence: 11.3] [Reference Citation Analysis]
39 Asgarshirazi M, Shariat M, Dalili H. Comparison of the Effects of pH-Dependent Peppermint Oil and Synbiotic Lactol (Bacillus coagulans + Fructooligosaccharides) on Childhood Functional Abdominal Pain: A Randomized Placebo-Controlled Study. Iran Red Crescent Med J. 2015;17:e23844. [PMID: 26023339 DOI: 10.5812/ircmj.17(4)2015.23844] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
40 Boeckxstaens G, Clavé P, Corazziari ES, Tack J. Irritable bowel syndrome: focus on otilonium bromide. Expert Rev Gastroenterol Hepatol 2014;8:131-7. [PMID: 24417261 DOI: 10.1586/17474124.2014.869477] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
41 Barouei J, Adams MC, Hodgson DM. Prophylactic role of maternal administration of probiotics in the prevention of irritable bowel syndrome. Med Hypotheses 2009;73:764-7. [PMID: 19481357 DOI: 10.1016/j.mehy.2009.04.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
42 Yan J, Xu Y, Hu B, Alnajm S, Liu L, Lu Y, Sun Z, Cheng F. TIBS: A web database to browse gene expression in irritable bowel syndrome. Journal of Theoretical Biology 2014;354:48-53. [DOI: 10.1016/j.jtbi.2014.03.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Esteban-Zubero E, López-Pingarrón L, Alatorre-Jiménez MA, Ochoa-Moneo P, Buisac-Ramón C, Rivas-Jiménez M, Castán-Ruiz S, Antoñanzas-Lombarte Á, Tan DX, García JJ, Reiter RJ. Melatonin's role as a co-adjuvant treatment in colonic diseases: A review. Life Sci 2017;170:72-81. [PMID: 27919824 DOI: 10.1016/j.lfs.2016.11.031] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
44 Mayer EA, Bradesi S, Chang L, Spiegel BM, Bueller JA, Naliboff BD. Functional GI disorders: from animal models to drug development. Gut. 2008;57:384-404. [PMID: 17965064 DOI: 10.1136/gut.2006.101675] [Cited by in Crossref: 116] [Cited by in F6Publishing: 114] [Article Influence: 7.7] [Reference Citation Analysis]
45 Kohen R, Jarrett ME, Cain KC, Jun SE, Navaja GP, Symonds S, Heitkemper MM. The serotonin transporter polymorphism rs25531 is associated with irritable bowel syndrome. Dig Dis Sci. 2009;54:2663-2670. [PMID: 19125330 DOI: 10.1007/s10620-008-0666-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
46 Ringel Y, Drossman DA. Irritable Bowel Syndrome. Netter's Internal Medicine. Elsevier; 2009. pp. 419-25. [DOI: 10.1016/b978-1-4160-4417-8.50066-8] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
47 Basu PP, Shah NJ, Krishnaswamy N, Pacana T. Prevalence of restless legs syndrome in patients with irritable bowel syndrome. World J Gastroenterol 2011; 17(39): 4404-4407 [PMID: 22110266 DOI: 10.3748/wjg.v17.i39.4404] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
48 Smith JL, Bayles D. Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis. J Food Prot 2007;70:1762-9. [PMID: 17685356 DOI: 10.4315/0362-028x-70.7.1762] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
49 Praveen V, Praveen S, Deshpande G, Patole SK; Cochrane Developmental, Psychosocial and Learning Problems Group. Oral probiotics for infantile colic. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd010986] [Cited by in Crossref: 6] [Article Influence: 0.8] [Reference Citation Analysis]
50 Szarka LA, Camilleri M, Burton D, Fox JC, McKinzie S, Stanislav T, Simonson J, Sullivan N, Zinsmeister AR. Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome. Clin Gastroenterol Hepatol 2007;5:1268-75. [PMID: 17900994 DOI: 10.1016/j.cgh.2007.07.011] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
51 Van Kerkhoven LA, Laheij RJ, Jansen JB. Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26:979-986. [PMID: 17877505 DOI: 10.1111/j.1365-2036.2007.03453.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 5.2] [Reference Citation Analysis]
52 Merchant JL. Tales from the crypts: regulatory peptides and cytokines in gastrointestinal homeostasis and disease. J Clin Invest 2007;117:6-12. [PMID: 17200701 DOI: 10.1172/JCI30974] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
53 Wilhelmsen M, Amirian I, Reiter RJ, Rosenberg J, Gögenur I. Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. J Pineal Res 2011;51:270-7. [PMID: 21615490 DOI: 10.1111/j.1600-079X.2011.00895.x] [Cited by in Crossref: 126] [Cited by in F6Publishing: 42] [Article Influence: 11.5] [Reference Citation Analysis]